Abstract
To the Editor: During the COVID-19 shutdown, the standard of care for melanoma treatment has been temporarily modified. The National Comprehensive Cancer Network (NCCN) and Society of Surgical Oncology recommended that excisional biopsies be performed whenever possible and that wide local excision and sentinel lymph node biopsy be deferred for up to 3 months for lesions with clear histologic margins (Fig 1).1,2 This decision was justified by the claim that “most time-to-treat studies show no adverse patient outcomes following a 90-day treatment delay,” but the supporting evidence has not been clearly presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
